US Bancorp
BRLI

US Bancorp’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

US Bancorp’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-9,656
Closed -$398K – 3796
2015
Q2 		$398K Sell
9,656
-9,303
-49% -$334K ﹤0.01% 1455
2015
Q1 		$668K Buy
18,959
+2,558
+16% +$86.5K ﹤0.01% 1216
2014
Q4 		$527K Sell
16,401
-259
-2% -$7.49K ﹤0.01% 1316
2014
Q3 		$467K Sell
16,660
-7,925
-32% -$241K ﹤0.01% 1355
2014
Q2 		$743K Sell
24,585
-4,089
-14% -$113K ﹤0.01% 1140
2014
Q1 		$794K Sell
28,674
-11,965
-29% -$313K ﹤0.01% 1077
2013
Q4 		$1.04M Sell
40,639
-3,347
-8% -$103K ﹤0.01% 903
2013
Q3 		$1.31M Buy
43,986
+2,240
+5% +$62.3K 0.01% 794
2013
Q2 		$1.2M Buy
+41,746
New +$1.15M 0.01% 799

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

US Bancorp's BRLI Position: Q3 2015 in Review

US Bancorp sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 9,656 shares — an estimated $398K sold.

US Bancorp first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.31M in Q3 2013. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • US Bancorp reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • US Bancorp sold 9,656 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $398K.
  • US Bancorp first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
  • US Bancorp's BIO-REFERENCE LABS INC-NEW- position peaked at $1.31M in Q3 2013.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on US Bancorp's 13F filing for Q3 2015, filed 16 Nov 2015.